Closed
SectorHealthcare
112.39 1.84
24h
Min
110.41
Max
112.7
Income | -468M 1.3B |
---|---|
Sales | -902M 6.7B |
P/E Sector Avg | 22.88 51.198 |
EPS | 1.81 |
Dividend yield | 2.9 |
Profit margin | 19.724 |
Employees | 17,600 |
EBITDA | -504M 2.6B |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +9.06% upside |
Dividend yield Sector Avg | 2.90% 2.40% |
---|---|
Next Earnings | 7 sie 2025 |
Next Dividend date | 27 cze 2025 |
Next Ex Dividend date | 13 cze 2025 |
Market Cap | 3.1B 135B |
---|---|
Previous open | 110.55 |
Previous close | 112.39 |
By Acuity
35%
65%
110 / 380 Ranking in Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 120.47 USD 9.06%
High 140 USD
Low 92 USD
Based on 20 Wall Street analysts offering 12 month price targets forGilead Sciences Inc. - Dist in the last 3 months.
By Acuity
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$